UnitedHealth Stock: Justice Department Probe Triggers Freefall

UnitedHealth Group finds itself in severe turmoil as shares plummeted nearly 11% to $245.90 following news of a U.S. Justice Department criminal investigation into potential Medicare fraud. The dramatic selloff represents the latest blow to the healthcare giant, whose stock has now fallen to its lowest level in four years. This investigation, reportedly focusing on the company's Medicare Advantage business practices, comes at a particularly vulnerable time for UnitedHealth, which was already reeling from the unexpected resignation of CEO Andrew Witty and the complete withdrawal of its financial guidance for 2025. The combination of these negative developments has sparked panic among investors, with some questioning whether this represents a temporary crisis or the beginning of a more profound decline.

Company's Defensive Stance

UnitedHealth has adopted a combative position in response to the allegations, claiming it has received no official notification regarding criminal investigations. The company went so far as to label the Wall Street Journal report that broke the news as "irresponsible." However, this defensive posture has done little to reassure the market, as investors continue to flee amid uncertainty about both the potential legal consequences and the company's underlying business fundamentals. What was once considered a healthcare sector stalwart now faces serious questions about its future trajectory and leadership.

Ad

Fresh Unitedhealth information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Source StockWorld